# AbbVie (ABBV) insider trading and SEC filings

AbbVie (ABBV) insider trades from SEC Form 4s: who traded, the transaction and the share count, each linked to EDGAR.

I read the 8 insider filings below, filed between May 12 and Oct 2, 2026, all on Form 4. Each one is about AbbVie stock and links to the original on EDGAR. They name 6 insiders: 5 directors and 1 officer. Of the filings, 1 reports an open-market sale, 1 an option exercise, and 3 a grant or award (some filings report more than one type). In the 1 filing reporting a sale, the same person also reports an option exercise on the same trade date. AbbVie's SEC record shows its latest 10-K filed Feb 20, 2026, its latest 10-Q Aug 3, 2026, and its latest 8-K Oct 5, 2026.

| Form | Filed | Insider | Transaction | Price | Trade date | Shares held after | Ownership |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 4 | 2026-10-02 | Quaggin Susan E — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-10-02 | RAPP EDWARD J — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-08-18 | Nicholas Donoghoe — EVP, CHIEF BUS/STRAT OFFICER | Option exercise · 32,710 shares | $79.02 | Aug 14, 2026 | 107,140 | Direct |
| 4 | 2026-08-18 | Nicholas Donoghoe — EVP, CHIEF BUS/STRAT OFFICER | Open-market sale · 32,710 shares | $250.00 | Aug 14, 2026 | 74,430 | Direct |
| 4 | 2026-07-02 | RAPP EDWARD J — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-07-02 | Quaggin Susan E — Director | not itemised — see the filing | — | — | — | — |
| 4 | 2026-05-12 | FALK THOMAS J — Director | Grant or award · 1,118 shares | — | May 8, 2026 | 2,321 | Direct |
| 4 | 2026-05-12 | WADDELL FREDERICK H — Director | Grant or award · 1,118 shares | — | May 8, 2026 | 30,076 | Direct |
| 4 | 2026-05-12 | Roberts Rebecca B — Director | Grant or award · 1,118 shares | — | May 8, 2026 | 14,846 | Direct |

Source: [https://pipthebot.com/insider/abbv/](https://pipthebot.com/insider/abbv/)

Pip is for research and education only — not investment advice, and not a recommendation to buy, sell, or hold any security. Pip reflects your own stated reasons against public information and never tells you what to do. You decide.